C19EARLY.ORG KEYWORD DENSITY CHECKER

Total words: 2127 | 2-word phrases: 583 | 3-word phrases: 609 | 4-word phrases: 610

PAGE INFO

Title Try to keep the title under 60 characters (61 characters)
COVID-19 early treatment: real-time analysis of 4,502 studies
Description Try to keep the meta description between 50 - 160 characters (79 characters)
COVID-19 early treatment: real-time analysis of 4,502 studies for 81 treatments
Keywords Meta keywords are not recommended anymore (79 characters)
COVID-19 early treatment COVID early treatment COVID-19 treatment treatments study studies research analysis COVID-19 early treatment: real-time analysis of 4,502 studies
H1 H1 tag on the page (61 characters)
COVID-19 early treatment: real-time analysis of 4,502 studies

ONE WORD PHRASES 325 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1meta8225.23%
2and144.31%
3studies82.46%
4of82.46%
5close82.46%
6treatments72.15%
7treatment72.15%
8the61.85%
9for61.85%
10 51.54%

TWO WORD PHRASES 583 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1meta close81.37%
2early treatment30.51%
3based on30.51%
4nigella sativa30.51%
54502 studies20.34%
6nasoorophar⏵ alkalinization20.34%
7monoclonals⏵ adintrevimab20.34%
8vitamins⏵ vitamin a20.34%
9covid19 early20.34%
10all studies early treatment20.34%
11mortality early mortality20.34%
12prophylaxis prophylaxis mortality20.34%
13analysis of20.34%
14antiandrogens⏵ all20.34%
15early treatments20.34%
16post share20.34%
17share covidanalysis20.34%
18treatments are10.17%
19are covered10.17%
20covered here10.17%

THREE WORD PHRASES 609 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1post share covidanalysis20.33%
2covid19 early treatment20.33%
3that prioritizes more10.16%
4stages see the10.16%
5treatment stages see10.16%
6different treatment stages10.16%
7and different treatment10.16%
8outcomes and different10.16%
9specific outcomes and10.16%
10for specific outcomes10.16%
11methods for specific10.16%
12for details see10.16%
13outcomes for details10.16%
14serious outcomes for10.16%
15more serious outcomes10.16%
16prioritizes more serious10.16%
17top all studies early treatment10.16%
18individual pages not10.16%
19cover the most10.16%
20shorter hospitalization p10.16%
21hospitalization p we10.16%
22p we aim10.16%
23we aim to10.16%
24aim to cover10.16%
25to cover the10.16%
26the most promising10.16%
27prespecified effect extraction10.16%
28early treatments for10.16%
29treatments for covid1910.16%
30for covid19 we10.16%

FOUR WORD PHRASES 610 Words

# Keyword H1 Title Des Volume Position Suggest Frequency Density
1top all studies early treatment mortality10.16%
2aim to cover the10.16%
3more serious outcomes for10.16%
4prioritizes more serious outcomes10.16%
5that prioritizes more serious10.16%
6criteria that prioritizes more10.16%
7use prespecified effect extraction10.16%
8we use prespecified effect10.16%
9covid19 we use prespecified10.16%
10for covid19 we use10.16%
11treatments for covid19 we10.16%
12early treatments for covid1910.16%
13cover the most promising10.16%
14to cover the most10.16%
15we aim to cover10.16%
16outcomes for details see10.16%
17p we aim to10.16%
18hospitalization p we aim10.16%
19shorter hospitalization p we10.16%
2041 shorter hospitalization p10.16%
21and 41 shorter hospitalization10.16%
22lower icu admission p0000510.16%
2377 lower icu admission10.16%
24p0001 77 lower icu10.16%
25mortality p0001 77 lower10.16%
26lower mortality p0001 7710.16%
2773 lower mortality p000110.16%
28rct 73 lower mortality10.16%
29treatment rct 73 lower10.16%
30serious outcomes for details10.16%
31methods for specific outcomes10.16%
32150 patient nigella sativa10.16%
33for many other treatments10.16%
34control group 2109 are10.16%
35a control group 210910.16%
36with a control group10.16%
37comparing with a control10.16%
38results comparing with a10.16%
39present results comparing with10.16%
402308 present results comparing10.16%

EXTERNAL LINKS

# URL Whois Check
1https://c19hcq.org/ Whoisc19hcq.org
2 https://c19ivm.org/ Whoisc19ivm.org
3 https://c19hcq.org/ Whoisc19hcq.org
4 https://c19hcq.org/meta.html Whoisc19hcq.org
5 https://c19ivm.org/ Whoisc19ivm.org
6 https://c19ivm.org/meta.html Whoisc19ivm.org
7 https://twitter.com/CovidAnalysis Whoistwitter.com
8 https://twitter.com/CovidAnalysis Whoistwitter.com
9 https://c19hcq.org/meta.html Whoisc19hcq.org
10 https://c19ivm.org/meta.html Whoisc19ivm.org
11 https://c19hcq.org/meta.html Whoisc19hcq.org
12 https://c19ivm.org/meta.html Whoisc19ivm.org
13 https://c19ivm.org/meta.html Whoisc19ivm.org
14 https://c19hcq.org/meta.html Whoisc19hcq.org
15 https://c19ivm.org/meta.html Whoisc19ivm.org
16 https://c19hcq.org/meta.html Whoisc19hcq.org
17 https://c19hcq.org/meta.html Whoisc19hcq.org
18 https://c19ivm.org/meta.html Whoisc19ivm.org
19 https://c19ivm.org/ Whoisc19ivm.org
20 https://www.medrxiv.org/content/10.1101/2021.06.01.21258147v2.full.pdf Whoismedrxiv.org
21 https://investor.regeneron.com/news-releases/news-release-details/regeneron-announces-new-us-government-agreement-purchase Whoisregeneron.com
22 https://www.clinicaltrialsarena.com/comment/eli-lillys-monoclonal-antibody-bamlanivimab/ Whoisclinicaltrialsarena.com
23 https://www.fiercepharma.com/pharma/astrazeneca-pledges-1m-more-evusheld-doses-to-u-s-for-a-total-covid-deal-worth-855m Whoisfiercepharma.com
24 https://www.medrxiv.org/content/10.1101/2021.06.01.21258147v2.full.pdf Whoismedrxiv.org
25 https://www.chinadaily.com.cn/a/202302/09/WS63e445f6a31057c47ebadc2a.html Whoiscom.cn
26 https://www.sciencedirect.com/science/article/pii/S2055664020300170 Whoissciencedirect.com
27 https://investor.lilly.com/news-releases/news-release-details/lilly-will-supply-600000-doses-bebtelovimab-us-government Whoislilly.com
28 https://asia.nikkei.com/Spotlight/Caixin/China-homegrown-COVID-pill-included-in-national-subsidy-program Whoisnikkei.com
29 https://www.medrxiv.org/content/10.1101/2021.06.01.21258147v2.full.pdf Whoismedrxiv.org
30 https://c19hcq.org/ Whoisc19hcq.org
31 https://www.sciencedirect.com/science/article/pii/S2055664020300182/pdf Whoissciencedirect.com
32 https://scrip.pharmaintelligence.informa.com/SC145859/Watch-This-Space-Glenmark-SaNOtizes-COVID-19-Nasal-Spray-Debuts-In-India Whoisinforma.com
33 https://biopharma.media/xocova-powerful-new-japanese-drug-for-coronavirus-treatment-3494/ Whoisbiopharma.media
34 https://www.fiercepharma.com/pharma/gsk-and-vir-tune-their-sotrovimab-pitch-heels-delta-busting-variant-data Whoisfiercepharma.com
35 https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-price-covid-19-drug-paxlovid-1400-five-day-course-wsj-2023-10-18/ Whoisreuters.com
36 https://www.sciencedirect.com/science/article/pii/S2055664020300182/pdf Whoissciencedirect.com
37 https://www.fiercepharma.com/pharma/icer-says-pfizers-paxlovid-mercks-molnupiravir-both-cost-effective-drugs-benefit-far-equal Whoisfiercepharma.com
38 https://www.chinadaily.com.cn/a/202302/09/WS63e445f6a31057c47ebadc2a.html Whoiscom.cn
39 https://www.globaltimes.cn/page/202208/1272362.shtml Whoisglobaltimes.cn
40 https://www.nytimes.com/2020/06/29/health/coronavirus-remdesivir-gilead.html Whoisnytimes.com
41 https://www.prnewswire.com/news-releases/plasma-therapy-global-market-report-2020-30-covid-19-growth-and-change-301102968.html Whoisprnewswire.com
42 https://c19ivm.org/ Whoisc19ivm.org
43 https://c19hcq.org/ Whoisc19hcq.org
44 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
45 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438859/ Whoisnih.gov
46 https://www.researchgate.net/publication/343305357_A_Case_Series_of_100_COVID-19_Positive_Patients_Treated_with_Combination_of_Ivermectin_and_Doxycycline Whoisresearchgate.net
47 http://www.medicineinsights.info/index.php/cmi/article/view/137 Whoismedicineinsights.info
48 https://www.worldwidejournals.com/international-journal-of-scientific-research-(IJSR)/recent_issues_pdf/2020/October/observational-study-on-clinical-features-treatment-and-outcome-of-covid-19-in-a-tertiary-care-centre-in-india--a-retrospective-case-series_October_2020_1614017661_0932284.pdf Whoisworldwidejournals.com
49 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
50 https://pubmed.ncbi.nlm.nih.gov/32740441/ Whoisnih.gov
51 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
52 https://www.amazon.com/Overcoming-COVID-Darkness-Successfully-Patients-ebook/dp/B09RPSXMQD Whoisamazon.com
53 https://rumble.com/vt62y6-covid-19-a-second-opinion.html Whoisrumble.com
54 https://www.medrxiv.org/content/10.1101/2022.04.04.22273356v1 Whoismedrxiv.org
55 https://twitter.com/jeffdavismd/status/1536872401711116291 Whoistwitter.com
56 https://twitter.com/Dhananj29209104/status/1478280379475787784 Whoistwitter.com
57 http://web.archive.org/web/20230115123101/https://twitter.com/btysonmd/status/1607599121594208256 Whoisarchive.org
58 https://filiperafaeli.substack.com/p/covid-19-the-doctor-who-failed-to Whoissubstack.com
59 https://www.cisteijournal.com/Files/Iodine-Oropharyngeal.pdf Whoiscisteijournal.com
60 https://www.amazon.com/Overcoming-COVID-Darkness-Successfully-Patients-ebook/dp/B09RPSXMQD Whoisamazon.com
61 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
62 https://drsyedhaider.com/covid-19/my-experience-flccc-treatment-and-prevention-protocols Whoisdrsyedhaider.com
63 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3779211 Whoisssrn.com
64 https://twitter.com/TheChiefNerd/status/1639099759754346503 Whoistwitter.com
65 https://web.archive.org/web/*/https://twitter.com/Covid19Crusher/status/1455292173386137600 Whoisarchive.org
66 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
67 https://www.wddty.com/features/cracking-the-covid-cure/ Whoiswddty.com
68 https://rumble.com/vt62y6-covid-19-a-second-opinion.html Whoisrumble.com
69 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
70 https://www.ijidonline.com/article/S1201-9712(20)32235-9/fulltext Whoisijidonline.com
71 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
72 https://web.archive.org/web/20211101221324/https://twitter.com/Covid19Crusher/status/1455292173386137600 Whoisarchive.org
73 https://www.mdpi.com/2673-8937/2/2/22 Whoismdpi.com
74 https://medwinpublishers.com/EIJ/repurposing-drugs-for-covid-19-by-a-developing-country.pdf Whoismedwinpublishers.com
75 https://twitter.com/SebaPop/status/1565781455988465665 Whoistwitter.com
76 https://ijirms.in/index.php/ijirms/article/view/1100 Whoisijirms.in
77 https://medicospelavidacovid19.com.br/editoriais/folha-de-s-paulo-revela-numeros-de-david-uip-veja-a-comparacao-com-medicos-que-fazem-tratamento-precoce/ Whoiscom.br
78 https://www.imrpress.com/journal/RCM/22/3/10.31083/j.rcm2203116 Whoisimrpress.com
79 https://www.cureus.com/articles/76496-therapies-to-prevent-progression-of-covid-19-including-hydroxychloroquine-azithromycin-zinc-and-vitamin-d3-with-or-without-intravenous-vitamin-c-an-international-multicenter-randomized-trial Whoiscureus.com
80 https://www.heraldopenaccess.us/openaccess/use-of-melatonin-as-adjunctive-treatment-and-prophylaxis-during-covid-19 Whoisheraldopenaccess.us
81 https://www.amazon.com/Overcoming-COVID-Darkness-Successfully-Patients-ebook/dp/B09RPSXMQD Whoisamazon.com
82 https://www.sciencedirect.com/science/article/pii/S2603924922000283 Whoissciencedirect.com
83 https://filiperafaeli.substack.com/p/the-anonymous-hero-of-the-pandemic Whoissubstack.com
84 https://www.authorea.com/users/465688/articles/560189-frequentist-and-bayesian-analysis-methods-for-case-series-data-and-application-to-early-outpatient-covid-19-treatment-case-series-of-high-risk-patients Whoisauthorea.com
85 https://twitter.com/CovidAnalysis Whoistwitter.com
86 http://creativecommons.org/publicdomain/zero/1.0?ref=chooser-v1 Whoiscreativecommons.org